O2h Ventures is an investment firm specializing in biotechnology, providing investors with opportunities to support promising medical innovations through the EIS (Enterprise Investment Scheme) and SEIS (Seed Enterprise Investment Scheme). Focused on backing groundbreaking biotech ventures, O2h Ventures facilitates investments that contribute to advancements in healthcare and medical science, leveraging tax-efficient investment schemes to enhance potential returns for investors.